Mariko Welch

Learn More
AIM Ruptured abdominal aortic aneurysm (rAAA) accounts for 10000 deaths annually in the UK. Deaths occur in the 6th and 7th decades with loss of potential years of life. Mortality rates of 5% to 8% are reported for elective AAA repair, but no significant improvement in emergency outcome, with community mortality remaining at 80% and operative mortality at(More)
AIM Methicillin resistant Staphylococcus aureus (MRSA) infection in vascular patients is associated with increased morbidity and mortality. We investigated whether routine MRSA screening reduced complications related to MRSA infection. METHODS Data was analysed for all MRSA positive (+ve) vascular patients admitted before (1996-2000) and after (2001-2004)(More)
AIM There is an increasing incidence of methicillin resistant Staphylococcus aureus (MRSA) following vascular surgery, which is associated with poor outcome. The risk factors and timing for MRSA acquisition have been established. We attempt to establish predictors of outcome in MRSA positive patients undergoing arterial reconstruction. METHODS Eighty-five(More)
AIM Mortality after ruptured abdominal aortic aneurysm (rAAA) remains high. Hardman et al. suggested that the following factors predict perioperative death: age >76 years, loss of consciousness, ECG confirmed ischemia, creatinine over 180 micromol/l and hemoglobin below 9 g/dl. A score of 3 or more had 100% mortality. A retrospective study was performed to(More)
Approximately 1-2% of the UK population suffers from venous ulcers. Incompetent perforator leg veins are thought to be a major contributory factor. Subfascial endoscopic perforator surgery treats incompetent perforators in a minimally invasive fashion with significant improvement in wound healing and reduction in ulcer recurrence rates.
BACKGROUND Cardiovascular implantable electronic device (CIED) pocket infections are often related to recent CIED placement or manipulation, but these infections are not well characterized. The clinical presentation of CIED pocket infection, based on temporal onset related to last CIED procedure, deserves further study. METHODS The MEDIC (Multicenter(More)
Orlistat was approved by the Food and Drug Administration in 1998 and has been shown to be superior to placebo in achieving weight loss. It is generally well tolerated. However, severe liver injury has been reported. We present a case of hepatic failure in a patient taking orlistat. A 54-year-old African-American woman with hypertension presented with(More)
  • 1